|Bid||124.00 x 100|
|Ask||150.00 x 100|
|Day's Range||131.30 - 133.06|
|52 Week Range||110.90 - 169.89|
|PE Ratio (TTM)||9.23|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Value investing is by nature contrarian and the underperformance of value stocks over the past few years could be a opportunity for long-term disciplined investors. Here are some of the deepest value stocks in the market using the strategy of legendary investor Ben Graham.
Oppenheimer's Hartaj Singh reitearted his bullish stance on United Therapeutics ( UTHR) on Wednesday, writing that upcoming catalysts in the next six to 12 months are critical to the stock, and, if they go well, could lead to it re-rating. The most important catalyst may be the FREEDOM-EV Phase 3 pivotal trial of Orenitram in pulmonary arterial hypertension.
E*Trade Financial, Statoil, Arena Pharmaceuticals, Johnson & Johnson and United Therapeutics highlighted as Zacks Bull and Bear of the Day